Business Context and Reporting Period
This Form 8-K was filed by Palisade Bio, Inc. on May 20, 2022. The filing addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the company's compliance with listing standards.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, or debt metrics. The only financial data point provided is the stock price performance triggering the notice:
- Stock Price: The closing bid price of the common stock was below $1.00 per share for 30 consecutive trading days preceding May 20, 2022.
- Trading Symbol: PALI (Nasdaq Capital Market).
Material Changes
The material event reported is the receipt of a Notice of Delisting or Failure to Satisfy a Continued Listing Rule from Nasdaq. Specifically, the company failed to meet the Minimum Bid Price Requirement (Rule 5550(a)(2)).
- Current Status: The notice has no immediate effect on the listing; the stock continues to trade on the Nasdaq Capital Market.
- Compliance Period: The company has 180 calendar days from the date of the notice to regain compliance.
- Compliance Criteria: To regain compliance, the closing bid price must be at least $1.00 for a minimum of 10 consecutive business days during the compliance period.
Outlook, Risks, and Management Commentary
Management Commentary: The company intends to monitor the closing bid price of its common stock and may consider implementing available options to regain compliance if appropriate.
Risks and Contingencies:
- Delisting Risk: If the company fails to regain compliance by the end of the 180-day period (or an additional 180-day period if eligible), the common stock will be subject to delisting.
- Additional Compliance Period: An additional 180-day period may be granted if the company meets the market value of publicly held shares requirement and other initial listing standards by the end of the first compliance period, provided the company indicates intent to cure the deficiency.
Investor Verification Checklist
- Verify the current closing bid price of PALI stock to assess progress toward the $1.00 threshold.
- Monitor the company's announcements regarding potential corporate actions (e.g., reverse stock splits) to regain compliance.
- Check the company's compliance with other Nasdaq listing standards, specifically the market value of publicly held shares, which is required to qualify for an additional compliance period.
- Review subsequent filings for updates on the compliance status before the 180-day deadline expires.